Clinical Trial Update: Vortioxetine Intravenous Infusion at Initiation of Oral Treatment With Vortioxetine in Patients With Depression [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intravenous vortioxetine initiation followed by oral vortioxetine in patients with major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Vortioxetine (vortioxetine)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED